Orphan
Drugs Markets for Biologics and Non-Biologics Application Report Provides:
- An Overview Of Orphan Drug Criteria, The History
Of The Orphan Drug Act And Its Influence And Advantages Inherent In Orphan Drug
Designation And Future Growth Trends; This Report Focuses On Biologics and
Non-Biologics.
- Analyses Of Global Market Trends, With Data From 2010 To 2012, And Projections Of Compound Annual Growth Rates (Cagrs) Through 2017.
- Detailed Discussion Of Successful Orphan Products.
- Detailed Analysis Of Blockbuster Orphan Drugs.
- The Rising Influence Of Pharmacogenomics In The Orphan Drug Market.
- A Discussion Of Specific Rare Diseases For Which Orphan Drugs Exist.
Analyses Of The Most Promising Therapeutic Areas In The Industry And Leading Orphan Drugs In These Areas.
- An Outline Of Legislation And Regulation, Including Public And Private Agencies Involved In Support And Development.
- Technology Trends Analysis Within The Orphan Drug Market.
- Comprehensive Company Profiles Of Major Players In The Industry.
- Analyses Of Global Market Trends, With Data From 2010 To 2012, And Projections Of Compound Annual Growth Rates (Cagrs) Through 2017.
- Detailed Discussion Of Successful Orphan Products.
- Detailed Analysis Of Blockbuster Orphan Drugs.
- The Rising Influence Of Pharmacogenomics In The Orphan Drug Market.
- A Discussion Of Specific Rare Diseases For Which Orphan Drugs Exist.
Analyses Of The Most Promising Therapeutic Areas In The Industry And Leading Orphan Drugs In These Areas.
- An Outline Of Legislation And Regulation, Including Public And Private Agencies Involved In Support And Development.
- Technology Trends Analysis Within The Orphan Drug Market.
- Comprehensive Company Profiles Of Major Players In The Industry.
Introduction
Study
Objectives
The Orphan Drug Market Is One Of The Fastest-Growing
Segments In The Pharmaceutical And Biotechnology Industry. Bcc’s Goal in
Conducting This Study Is to Provide an Overview of the Current and Future
Global Market for Orphan Drugs. The Key Objective Is To Present A Comprehensive
Analysis Of Current Orphan Drugs And Those Under Development As Important
Therapies And Treatments For Rare Diseases.
This Report Explores Present And Future Strategies
And Regulations Within The Orphan Drug Market, Advances In The Market, The
Setbacks, The Current Situation And The Needs Of The Market. The Market for
Each Drug Listed By Its Generic Name/Active Ingredient And Approved
Indication(S) Is Also Analyzed In This Report.
Complete Report Copy of Orphan Drugs Markets for
Biologics @ http://www.rnrmarketresearch.com/global-markets-for-orphan-drugs-focus-on-biologics-market-report.html.
Order/Buy a Report Copy @ http://www.rnrmarketresearch.com/contacts/purchase?rname=99895.
A Detailed Analysis Of The Structure Of The Orphan
Drug Industry Has Been Conducted. Revenues Are Broken Down By Region Drug Type
(I.E., Biological And Nonbiological), Active Ingredient And Area Of Medical
Application. Sales Figures Are Estimated For The Five-Year Period From 2012
Through 2017.
Applications For Orphan Drugs Are Also Discussed In
The Report, With An Emphasis On The Usage Of The Drugs In Various Disease
Segments. The Report Also Covers Significant Patents And Their Allotments In
Each Category.
Reasons
for Doing This Study
Extensive Research In The Field Of Orphan Drugs Has
Resulted In Therapeutic Treatments For A Number Of Rare Diseases. Most Of The
Big Pharmaceutical Companies Have Now Begun To Explore The Advantages Of Orphan
Drugs As A Major Source Of Profit And A Steady Market.
R&D Spending, Competition And New Technologies
Are Increasing. Advances, New Product Launches And Assistance From Regulatory
Bodies Are Positively Impacting The Growth Of The Market For Orphan Drugs In
The Near Term. This Study Examines These Factors.
Contributions
of the Study and Intended Audience
This Study Focuses On The Manufacturers And Users Of
Orphan Drugs And Its Market Growth. Pharmaceutical Biotechnical Companies,
Research Institutes And Physicians Will Find This Study To Be Of Interest.
Complete Report Copy of Orphan Drugs Markets for Non-Biologics
@ http://www.rnrmarketresearch.com/global-markets-for-orphan-drugs-focus-on-non-biologics-market-report.html.
Order/Buy a Report Copy @ http://www.rnrmarketresearch.com/contacts/purchase?rname=99896.
Scope
of the Study
The Scope Of This Study Includes Orphan Drugs In
Pharmaceutical Markets Worldwide. Bcc Analyzes Each Market And Its
Applications, Regulatory Environment, Technology, Market Projections And Market
Shares. Technological Issues Include The Latest Trends And Developments. The
Emerging Market For Orphan Drugs Includes Countries Such As India, China,
Japan, Korea, Taiwan, Canada, Africa, Australia And New Zealand.
Methodology
Both Primary And Secondary Research Methodologies
Were Used In Preparing This Study. Bcc Conducted A Comprehensive Literature
Search, Which Included Technical Newsletters And Journals And Many Other
Sources. Projections Were Based On Estimates Such As The Current Number Of End
Users, Potential End Users, Mergers And Acquisitions And Market Trends.
Information
Sources
Many Companies Were Surveyed To Obtain Data For This
Study. Included Were Manufacturers And End Users Of Orphan Drugs Within The
Therapeutic Categories Examined And Various Disease Sector Industries. Data
Were Gathered From Various Industry Sources. Bcc Spoke With Officials Within
The Industry, Consulted Newsletters, Company Literature, Product Literature And
A Host Of Technical Articles, Journals, Indexes And Abstracts. Exhaustive
Investigations Of Databases By Key Terminology Were Completed. In Addition,
Data Were Compiled From Current Financial, Trade And Government Sources.
For
more details contact Mr. Priyank Tiwari: sales@rnrmarketresearch.com / +18883915441
Website:
http://www.rnrmarketresearch.com